Anafiltamig
Product Specifications
CAS Number
3009026-69-8
Target
Others, Immunology/Inflammation related, Integrin
Related Pathways
Immunology/Inflammation, Cytoskeletal Signaling, Others
Bioactivity
Anafiltamig is a trivalent monoclonal antibody inhibitor targeting CD79B, CD3E, and MS4A1. It consists of a humanized IgG1κ anti-CD79B arm and a bispecific scFv arm targeting CD3E and MS4A1. Anafiltamig can simultaneously bridge T cells and B cells, thus activating T cells to selectively kill B-cell tumors. This compound is applicable for research on B-cell malignancies, such as non-Hodgkin lymphoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog